Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 9
2.1 What Is This Report About?
9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetic Care
Devices 10
3.2 Glucose Monitoring Devices 10
3.2.1 Blood Glucose
Meters 10
3.2.2 Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 InsulinPens 10
3.3.2 Insulin Syringes 11
3.3.3 Insulin Pumps
11
3.3.4 Traditional Insulin Pump Accessories 11
4 Healthcare Sector
Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure
13
4.2.1 Healthcare Personnel Data 14
4.2.2 Healthcare Facilities Data
15
4.3 Healthcare Policy 18
5 Regulation System 19
5.1 Medical
Equipment Approval Process 19
5.1.1 Classification 19
5.1.2
Registration and Conformity assessment 20
5.1.3 China Compulsory
Certificate (CCC Mark) 22
5.1.4 Labeling and Packaging 23
5.1.5
Registration Fee 24
5.1.6 Registration Period 24
5.2 Post Market
Surveillance (PMS) 24
6 Pricing and Reimbursement 25
7 Distribution
Structure 27
8 Diabetes Care Devices In China 28
8.1 Diabetes Care
Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 28
8.2
Diabetes Care Devices, China, Overall Revenue ($ mn), 2000-2015 29
8.3
Diabetes Care Devices, China, Category Volume (Units), 2000-2015 33
8.4
Diabetes Care Devices, China, Company Share (2007-2008) 36
9 Glucose
Monitoring In China 37
9.1 Glucose Monitoring Overall Revenue (2000-2015)
37
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 39
9.2
Glucose Monitoring Overall Volume (2000-2015) 41
9.2.1 Blood Glucose
Meters Overall Volume (2000-2015) 43
9.3 Glucose Monitoring Average Price
(2000-2015) 45
9.4 Glucose Monitoring Distribution Share (2007-2008)
45
9.5 Glucose Monitoring, China, Company Share (2007-2008) 46
10
Insulin Delivery In China 47
10.1 Insulin Delivery Overall Revenue
(2000-2015) 47
10.1.1 Insulin Pens Overall Revenue (2000-2015) 49
10.2
Insulin Delivery Overall Volume (2000-2015) 51
10.2.1 Insulin Pens Overall
Volume (2000-2015) 52
10.3 Insulin Delivery Average Price (2000-2015)
54
10.4 Insulin Delivery Distribution Share (2007-2008) 55
10.5
Insulin Delivery, China, Company Share (2007-2008) 56
11 Overview of Key
Companies in China Diabetes Care Devices Market 57
11.1 F. Hoffmann-La
Roche Ltd. 57
11.1.1 Company Overview 57
11.1.2 Value Chain Analysis
58
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 60
11.2 LifeScan,
Inc. 61
11.2.1 Company Overview 61
11.2.2 LifeScan, Inc. Pipeline
Products 61
11.3 Medtronic, Inc. 63
11.3.1 Company Overview 63
11.3.2 Value Chain Analysis 64
11.3.3 Medtronic, Inc. Pipeline Products
65
11.4 Novo Nordisk A/S 73
11.4.1 Company Overview 73
11.4.2 Novo
Nordisk A/S Pipeline Products 73
11.5 Becton, Dickinson and Company 74
11.5.1 Company Overview 74
11.5.2 Value Chain Analysis 74
11.6 ARKRAY,
Inc. 76
11.6.1 Company Overview 76
11.6.2 ARKRAY, Inc. Pipeline
Products 76
11.7 Terumo Corporation 78
11.7.1 Company Overview 78
11.7.2 Value Chain Analysis 78
11.8 Animas Corporation 81
11.8.1
Company Overview 81
11.9 Sanofi-Aventis 81
11.9.1 Company Overview
81
11.10 Smiths Medical 81
11.10.1 Company Overview 81
11.10.2
Value Chain Analysis 82
11.11 BIONIME Corporation 84
11.11.1 Company
Overview 84
11.12 Bayer HealthCare AG 84
11.12.1 Company Overview
84
11.12.2 Value Chain Analysis 85
11.12.3 Bayer HealthCare AG
Pipeline Products 87
11.13 Abbott Laboratories 88
11.13.1 Company
Overview 88
11.13.2 Value Chain Analysis 89
11.13.3 Abbott
Laboratories Pipeline Products 91
11.14 Apex Biotechnology Corp. 93
11.14.1 Company Overview 93
11.15 AViTA Corporation 93
11.15.1 Company
Overview 93
11.16 Wuxi Xinda Medical Equipment Co., Ltd. 93
11.16.1
Company Overview 93
12 Appendix 94
12.1 Global Markets Direct Research
Methodology 94
12.2 Coverage 95
12.3 Secondary Research 95
12.4
Primary Research 96
12.5 Models 96
12.6 Forecasts 97
12.7 Expert
Panel Validation 97
12.8 Currency Conversion 98
12.9 Contact Us 99
12.10 Disclaimer 99
1.1 List of Tables
Table 1: Doctors
by Specialty in China, 2003-2007 14
Table 2: Hospital Wards by Specialty
in China, 2003 - 2007 15
Table 3: Healthcare Institutions in China,
2000-2004 16
Table 4: Personnel Employed in Healthcare Institutions in
China, 2000-2004 16
Table 5: Healthcare Institutions, Hospital Beds and
Employed Personnel by Region in China, 2004 17
Table 6: Diabetes Care
Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 28
Table 7:
Diabetes Care Devices, China, Overall Revenue ($ mn), 2000-2015 29
Table 8: Diabetes Care Devices, China, Cross-Category Analysis, 2000-2015
30
Table 9: Diabetes Care Devices, China, Overall Revenue ($ mn),
Historic, 2000-2008 31
Table 10: Diabetes Care Devices, China,
Overall Revenue ($ mn), Forecast, 2008-2015 32
Table 11: Diabetes
Care Devices, China, Category Volume (Units), 2000-2015 33
Table 12:
Diabetes Care Devices, China, Category Volume (Units), Historic, 2000-2008
34
Table 13: Diabetes Care Devices, China, Category Volume (Units),
Forecast, 2008-2015 35
Table 14: Diabetes Care Devices, China,
Company Share by Revenue ($ mn), 2007-2008 36
Table 15: Glucose
Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2008 37
Table
16: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast,
2008-2015 38
Table 17: Blood Glucose Meters, China, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 39
Table 18: Blood Glucose Meters,
China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 40
Table 19:
Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2008
41
Table 20: Glucose Monitoring, China, Volume (Units) by Segment,
Forecast, 2008-2015 42
Table 21: Blood Glucose Meters, China, Volume
(Units) by Sub-Segment, Historic, 2000-2008 43
Table 22: Blood
Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
44
Table 23: Glucose Monitoring, China, Average Price ($), Historic,
2000-2008 45
Table 24: Glucose Monitoring, China, Average Price ($),
Forecast, 2008-2015 45
Table 25: Glucose Monitoring, China,
Distribution Share by Revenue ($mn), 2007-2008 45
Table 26: Glucose
Monitoring, China, Company Share by Revenue ($ mn), 2007-2008 46
Table 27:
Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
47
Table 28: Insulin Delivery, China, Revenue ($ mn) by Segment,
Forecast, 2008-2015 48
Table 29: Insulin Pens, China, Revenue ($ mn)
by Sub-Segment, Historic, 2000-2008 49
Table 30: Insulin Pens, China,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 50
Table 31:
Insulin Delivery, China, Volume (Units) by Segment, Historic, 2000-2008 51
Table 32: Insulin Delivery, China, Volume (Units) by Segment, Forecast,
2008-2015 51
Table 33: Insulin Pens, China, Volume (Units) by
Sub-Segment, Historic, 2000-2008 52
Table 34: Insulin Pens, China,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 53
Table 35:
Insulin Delivery, China, Average Price ($), Historic, 2000-2008 54
Table
36: Insulin Delivery, China, Average Price ($), Forecast, 2008-2015
54
Table 37: Insulin Delivery, China, Distribution Share by Revenue
($mn), 2007-2008 55
Table 38: Insulin Delivery, China, Company Share
by Revenue ($ mn), 2007-2008 56
Table 39: F. Hoffmann-La Roche Ltd
Pipeline Products by Equipment Type 60
Table 40: F. Hoffmann-La Roche
Ltd Pipeline Products by Development Stage 60
Table 41: F.
Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 60
Table 42:
LifeScan, Inc. Pipeline Products by Equipment Type 61
Table 43:
LifeScan, Inc. Pipeline Products by Development Stage 61
Table 44:
LifeScan, Inc. Pipeline Products by Therapy Area 61
Table 45:
LifeScan, Inc. Pipeline Products by Clinical Trials 62
Table 46:
LifeScan, Inc. Pipeline Products by News Summary 62
Table 47:
Medtronic, Inc. Pipeline Products by Equipment Type 65
Table 48:
Medtronic, Inc. Pipeline Products by Development Stage 67
Table 49:
Medtronic, Inc. Pipeline Products by Therapy Area 69
Table 50:
Medtronic, Inc. Pipeline Products by Clinical Trials 71
Table 51:
Medtronic, Inc. Pipeline Products by News Summary 72
Table 52: Novo
Nordisk A/S Pipeline Products by Equipment Type 73
Table 53: Novo
Nordisk A/S Pipeline Products by Development Stage 73
Table 54: Novo
Nordisk A/S Pipeline Products by Therapy Area 73
Table 55: Novo
Nordisk A/S Pipeline Products by Clinical Trials 73
Table 56: ARKRAY,
Inc. Pipeline Products by Equipment Type 76
Table 57: ARKRAY, Inc.
Pipeline Products by Development Stage 76
Table 58: ARKRAY, Inc.
Pipeline Products by Clinical Trials 77
Table 59: ARKRAY, Inc.
Pipeline Products by News Summary 77
Table 60: Bayer HealthCare AG
Pipeline Products by Equipment Type 87
Table 61: Bayer HealthCare AG
Pipeline Products by Development Stage 87
Table 62: Bayer HealthCare
AG Pipeline Products by Therapy Area 87
Table 63: Bayer HealthCare AG
Pipeline Products by News Summary 87
Table 64: Abbott Laboratories
Pipeline Products by Equipment Type 91
Table 65: Abbott Laboratories
Pipeline Products by Development Stage 91
Table 66: Abbott
Laboratories Pipeline Products by Therapy Area 91
Table 67: Abbott
Laboratories Pipeline Products by Clinical Trials 92
Table 68: Abbott
Laboratories Pipeline Products by News Summary 92
Table 69: USD to
Local Currency, Average Exchange Rate 2008 98
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in China, 2000 - 2005
13
Figure 2: Medical Equipment Registration Process in China, 2007 21
Figure 3: CCC Mark Certification Process in China, 2007 23
Figure 4:
Diabetes Care Device, Cross Country Comparison, Revenue ($ mn), 2000-2015
28
Figure 5: Diabetes Care Devices, China, Overall Revenue ($ mn),
2000-2015 29
Figure 6: Diabetes Care Devices, China, Cross-Category
Analysis, 2000-2015 30
Figure 7: Diabetes Care Devices, China,
Overall Revenue ($ mn), Historic, 2000-2008 31
Figure 8: Diabetes
Care Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015 32
Figure
9: Diabetes Care Devices, China, Category Volume (Units), 2000-2015
33
Figure 10: Diabetes Care Devices, China, Category Volume (Units),
Historic, 2000-2008 34
Figure 11: Diabetes Care Devices, China,
Category Volume (Units), Forecast, 2008-2015 35
Figure 12: Diabetes
Care Devices, China, Company Share (%), 2008 36
Figure 13: Glucose
Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2008 37
Figure 14: Glucose Monitoring, China, Revenue ($ mn) by Segment,
Forecast, 2008-2015 38
Figure 15: Blood Glucose Meters, China,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 39
Figure 16:
Blood Glucose Meters, China, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 40
Figure 17: Glucose Monitoring, China, Volume (Units) by
Segment, Historic, 2000-2008 41
Figure 18: Glucose Monitoring, China,
Volume (Units) by Segment, Forecast, 2008-2015 42
Figure 19: Blood
Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
43
Figure 20: Blood Glucose Meters, China, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 44
Figure 21: Glucose Monitoring,
China, Company Share (%), 2008 46
Figure 22: Insulin Delivery, China,
Revenue ($ mn) by Segment, Historic, 2000-2008 47
Figure 23: Insulin
Delivery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015 48
Figure
24: Insulin Pens, China, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 49
Figure 25: Insulin Pens, China, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 50
Figure 26: Insulin Pens, China,
Volume (Units) by Sub-Segment, Historic, 2000-2008 52
Figure 27:
Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015 53
Figure 28: Insulin Delivery, China, Company Share (%), 2008 56
Figure
29: F. Hoffmann-La Roche Ltd Value Chain Analysis 58
Figure 30:
Medtronic, Inc. Value Chain Analysis 64
Figure 31: Becton, Dickinson
and Company Value Chain Analysis 74
Figure 32: Terumo Corporation
Value Chain Analysis 78
Figure 33: Smiths Medical Value Chain
Analysis 82
Figure 34: Bayer HealthCare AG Value Chain Analysis
85
Figure 35: Abbott Laboratories Value Chain Analysis 89
Figure
36: Global Markets Direct Methodology 94
|
Related Report
|
View Cart
